health

Scientists uncover hidden inherited form of aggressive prostate cancer

Scientists uncover hidden inherited form of aggressive prostate cancer

Dr. Alexander Wyatt, associate professor of urologic sciences at UBC’s Faculty of Medicine said: “What’s striking is that every patient we identified with this inherited mutation had already developed metastatic disease by the time they were diagnosed. Wyatt, who is also a senior research scientist at the Vancouver Prostate Centre and BC Cancer, said the availability of existing testing technology could accelerate the translation of the discovery into clinical practice.

By Sola Ogundipe A man could inherit a genetic mutation that silently puts him at risk of an aggressive form of prostate cancer, develop the disease in his 40s and discover it only after the cancer has spread beyond the prostate. Scientists say they have uncovered a previously unknown hereditary pathway that could help explain some of these devastating cases.

The discovery, by researchers at the University of British Columbia (UBC), Canada, has identified inherited mutations in a gene known as CDK12 as a potential cause of exceptionally aggressive prostate cancer, challenging the long-held belief that changes in the gene occur only within cancer cells during tumour development. Although extremely rare, the finding could have far-reaching implications for families with a history of prostate cancer, particularly those in which men develop the disease unusually early or are diagnosed after it has spread.

In a study published in the journal Cancer Discovery, researchers analysed genetic data from more than 4,500 people with aggressive prostate cancer and identified five unrelated men carrying inherited CDK12 mutations. The disturbing finding was that all five developed metastatic prostate cancer between the ages of 44 and 62. Metastatic cancer means the disease has spread beyond its original location, making treatment more challenging and reducing the prospects of a cure.

The researchers said the discovery offers an opportunity to identify unsuspecting family members carrying the same mutation before they develop cancer or, more importantly, before the disease reaches an advanced stage. Dr. Alexander Wyatt, associate professor of urologic sciences at UBC’s Faculty of Medicine said: “What’s striking is that every patient we identified with this inherited mutation had already developed metastatic disease by the time they were diagnosed.

The opportunity now is to identify these families earlier and give people the chance to benefit from enhanced screening, when there are still curative treatment options.” Wyatt, who is also a senior research scientist at the Vancouver Prostate Centre and BC Cancer, said the availability of existing testing technology could accelerate the translation of the discovery into clinical practice.

“One of the most exciting aspects of this discovery is that we already have the technology needed to act on it. Adding CDK12 to existing genetic tests is relatively straightforward, which means this discovery could move from the research lab into clinical care much more quickly,” he said. The findings add a new dimension to the growing understanding of hereditary cancers.

While most cancers arise from genetic changes acquired during a person’s lifetime, an estimated five to 10 per cent are associated with inherited mutations that can be passed from parents to children. BRCA1 and BRCA2 are among the best-known examples, CDK12 could now become another important gene in the search for families vulnerable to aggressive cancer.

For years, scientists believed that harmful CDK12 alterations were acquired spontaneously within cancer cells rather than inherited from parents. The new study challenges that assumption. To establish whether the mutations were directly involved in causing the cancer, the researchers examined the tumours for a distinctive molecular pattern associated with the loss of CDK12 function.

They found a genetic fingerprint linking the inherited mutations to the development of the cancers, providing evidence that the mutations were not merely incidental findings. Dr. Sofie Tolmeijer, a postdoctoral fellow in the Wyatt laboratory said: “The tumours provided us with a genetic signature that pointed directly back to CDK12. It gave us compelling evidence that these inherited mutations were playing a direct role in causing their cancer.

“While this mutation is extremely rare, the discovery could be lifesaving for the families who carry it,” Tolmeijer said. Despite the potentially serious consequences, inherited CDK12 mutations remain exceptionally uncommon. They were identified in approximately one out of every 1,000 people with aggressive prostate cancer. However, researchers estimate that hundreds of families worldwide could carry the mutation, making its identification important despite its rarity.

The most immediate implication of the discovery is the possibility of incorporating CDK12 into existing genetic testing panels for hereditary prostate cancer. The researchers said the technology needed to detect CDK12 mutations is already available, meaning its inclusion in existing tests would not require the development of an entirely new diagnostic system.

For families affected, identifying one carrier could open the door to testing other relatives and determining who might also be at risk. Beyond prostate cancer, the researchers also uncovered evidence suggesting that inherited CDK12 mutations may be associated with ovarian cancer, although the relationship remains to be established. Some

  • cancer
  • prostate
  • mutation
  • discovery
  • disease
  • family
  • scientist
  • form

Summaries and tags are generated automatically. Stay informed with VidiaNews.

Related news

Only 20% of Nigeria’s 30,000 PHCs functional, family physicians raise alarm
health

Only 20% of Nigeria’s 30,000 PHCs functional, family physicians raise alarm

By Matthew Johnson The Society of Family Physicians of Nigeria, SOFPON, yesterday raised the alarm over the state of primary healthcare in the country, revealing that only about 20 per cent of more than 30,000 Primary Healthcare Centres ,PHCs, nationwide are fully functional. Vice-President of SOFPON, Dr Ibrahim Yakubu, who disclosed this during a press conference themed, “Primary Health Care Without Family Physicians: Can Nigeria Afford the Gap?”, will also focus on “The Double Burden of Disease and the Cost of Fragmented Care” and “The Stressed Family Physician and Continuity of Care”.

Read →
Judge approves $7.25bn Bayer payout to settle claims that Roundup causes cancer
health

Judge approves $7.25bn Bayer payout to settle claims that Roundup causes cancer

German company faced 65,000 claims from people who said they developed cancer after using weedkiller A Missouri judge on Friday approved Bayer’s $7.25bn settlement of lawsuits ⁠alleging that its weedkiller ​Roundup causes cancer, potentially resolving litigation that has weighed on the German company for close to a decade. Judge Timothy Boyer of a state court in St Louis ⁠found the settlement “fair, reasonable and adequate”.

Read →
Bring in ‘cosmetic cowboys’ law to avoid more deaths, says family of butt lift victim
health

Bring in ‘cosmetic cowboys’ law to avoid more deaths, says family of butt lift victim

Relatives speak out after inquest jury find Alice Webb’s death after filler entered her organs was accidental The family of a woman who died after a botched Brazilian butt lift have called for laws against “cosmetic cowboys” to be introduced before more people lose their lives. Speaking as an inquest jury concluded Alice Webb’s death was accidental, her family said they were astonished people were still having BBLs despite what had happened to her.

Read →
Ebola killed 46 members of one man’s family. Now he is fighting to save the rest
health

Ebola killed 46 members of one man’s family. Now he is fighting to save the rest

Ebola killed 46 members of one man’s family. Six months after the Bundibugyo strain swept through eastern DR Congo, Sylvain Kabona Tibasima is still trying to warn friends and family about the dangers of the virus The day Birungi Nembe was born in a hospital in Bunia, in the eastern Democratic Republic of the Congo, her mother, Sylvie Bongerize Tibasima, 46, was diagnosed with Ebola.

Read →